The Canadian Immuno-Oncology Summit 2017 is a one day event being held Friday, September 15th 2017 in Toronto, Ontario. The Summit will be chaired by Dr. Sunil Verma and Dr. Rosalyn Juergens.
This year's program will cover a variety of important topics examining advances in immuno-oncology and also explore topics that pertain to clinical practice, adverse event management and the pharmacoeconomics of novel therapies. This event will draw from experts in immuno-oncology from across North America.
Early Bird Price
Physicians: $129 CAD
Physicians: $179 CAD
About the Chair:
Dr. Sunil Verma, MD, MSEd, FRCPC is a Professor at the University of Calgary and Medical Director at the Tom Baker Cancer Centre. He completed his internal medicine and medical oncology training at the University of Alberta and then went on to a fellowship in breast cancer at the University of Toronto. He also completed his Master of Science in medical education from the University of California during his fellowship years.
Dr. Verma’s main clinical interests are in the treatment and management of breast cancer and lung cancer. He also has key research interests in neoadjuvant and endocrine treatment of breast cancer, reducing toxicity of systemic treatment, and developing novel therapies in breast and lung cancer. He has won numerous teaching awards and has also been recognized with many awards for his mentorship.
Dr. Rosalyn Juergens, BS, MD, PhD is a Medical Oncologist at the Juravinski Cancer Centre in Hamilton, Ontario, Canada where she specializes in lung, stomach and esophageal cancers. She is also an Associate Professor in the Department of Oncology at McMaster University. Her research focus has been in developmental therapeutics with a concentration on Phase I and II clinical trials. She has several research interests. She has research expertise in functional imaging and has conducted phase I clinical trials with novel imaging probes. Her work in developmental therapeutics has focused on epigenetics, immuno-oncology and targeted therapies.
Member Comments. (0)
Please log in to add a comment.